PRINTO (the Paediatric Rheumatology International Trials Organisation)

Institute of Child Health

Status: Unknown

Conditions: Juvenile Idiopathic Arthritis

Treatments: Drug: methotrexate

Study type: Observational

Funder types: Other

Identifiers

NCT00415935

04RU01

Details and patient eligibility

About

A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months

Sex: All

Ages: Under 16 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Any child with JIA who has gone into remission using methotrexate